Basel Medical Group Ltd (BMGL) stock

BMGLNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends June 30

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 30, 2026Score 3/30

$0.47−0.10 (-17.54%)

Close on Nov 13, 2026Market cap $743.59KP/E –Yield –

Basel Medical enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Basel Medical's enterprise value was $9.66M on Nov 11, 2026, against $272.13M a year earlier.

Period	Period end	Value	Change
2026	Nov 11, 2026	$9.66M	-91.6%
2025	Dec 31, 2025	$114.35M	–

Parsed from the XBRL in Basel Medical's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-12 reverse split on Jun 22, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BMGL.

Revenue growth45.2% · median -15.3%

Net margin-4.5% · median -63.1%

Advertisement
300 × 250

See a number that looks wrong?